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Case presentation
Dr Frizzi and Dr Bruni: A 75-year-old woman was admitted
to the emergency department for lithium intoxication man-
ifested acutely with diffuse weakness and slurred speech.
Some days earlier the patient had presented serious symp-
toms of diarrhoea. The patient had been under treatment with
carbolithium (300 mg once daily) for several years due to
major depressive syndrome. On arrival vital parameters were
stable, Glasgow Coma Scale (GCS) was 15/15, there were no
focal neurological deficits, and no meningeal signs
(Table 1). The patient denied alcohol consumption, or recent
trauma. Brain CT scan, chest and abdominal X-ray and
abdominal ultrasound examinations performed on admission
showed no significant alterations. An EKG showed sinus
rhythm at 65 bpm, normal atrioventricular conduction,
normal electrical axis, normal depolarization; and normal
ventricular repolarization. Laboratory studies showed renal
impairment (urea 66 mg/dl and creatinine 1.71 mg/dl), ele-
vated sodium (152 mEq/l) and lithium (2.36 mmol/l; n.v.
0,5-1 mmol/l) levels, and a mild macrocytic normochromic
anemia (Hb 10.6 g/dl). Other laboratory tests performed
were in the normal ranges (Table 2).
Differential diagnosis and clinical approach
Prof. Pastorelli and Dr Bocchi: First we performed an
arterial blood gas analysis (BGA) to rule out any possible
underlying metabolic and respiratory disorders: BGA
showed anion gap metabolic acidosis (pH 7.26, bicarbonate
16.1 mmol/l, AG 15.6 mEq/l), abnormal sodium levels
(156 mEq/l) and severe hyperosmolarity (317.3 mmol/kg).
We then administered hydration with half-normal saline
solution and 5 % dextrose solution in accordance with inter-
national guidelines, and opted for a period of clinical obser-
vation. Since serum levels of lithium were in initial reduction
after therapy, haemodialysis was deemed unnecessary.
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On the second day, the patient’s neurological status
worsened GCS 11/15 (E2?V4?M5): therefore, searching
for an unidentified cerebral problem, we ordered an elec-
troencephalogram (EEG) considering that a severe meta-
bolic encephalopathy was becoming increasingly plausible.
As we feared, the EEG showed diffuse paroxysmal activity
with triphasic voltage consistent with metabolic encepha-
lopathy. The same evening the patient presented a fever
(auricular temperature 39C).
Since the patient had a bladder catheter, we collected
blood and urine samples for culture looking for a possible
complicated urinary tract infection (UTI) in a patient with a
bladder catheter. A broad spectrum antibiotic piperacillin/
tazobactam iv titrated to renal function was initiated. The
same day, urinalysis showed hypoconcentrated urine (a
specific gravity of 1,004) and signs of bacterial growth:
these findings supported a diagnosis of renal diabetes in-
sipidus [1] and UTI.
On the third day, the patient became critical: vital
parameters were worsening (arterial blood pressure was
80/40 mmHg), GCS was 4/15 (E1?V2?M1) and neuro-
logical examination showed flaccid paralysis in all limbs
and the absence of reflexes. BGA showed initial sodium
and osmolarity reduction while lactate increased
(1.6 mmol/l).
On the fourth day, the GCS was 3/15 (E1?V1?M1) and
the arterial blood pressure was 70/30 mmHg: we started
norepinephrine IV infusion (0.2 lg/kg/min). BGA showed
moderate improvement in oxygenation, sodium concen-
tration (151 mEq/l) and osmolarity (310 mmol/kg).
Creatinine was 3.3 mg/dl, urea was 208 mg/dl and
inflammatory markers were rising (C-Reactive Protein
16.14 mg/dl; procalcitonin 36.36 ng/ml), whereas lithium
levels were reduced (1.28 mmol/l) and electrolytes and
osmolarity were improving (sodium 148 mEq/l and
osmolarity 303.9 mmol/kg).
On the fifth day, there was an onset of atrial fibrillation
with a fast ventricular response, which was treated with
digoxin. At this point there were two emerging problems:
(1) a septic state, which could not entirely justify the
worsened neurological condition, and (2) a worsening
encephalopathy, which was not consistent with the
improvement in blood electrolytes, osmolarity and lithium,
levels. At this point, because of the possibility of an
osmotic demyelination syndrome, we decided to perform a
brain MRI imaging study. The patient died about 4 h after
the MRI execution because of cardio-respiratory and arrest,
resuscitation attempts were unsuccessful.
Radiological diagnosis
Dr. Romano: Central pontine and extra-pontine osmotic
demyelinating syndromes (CPM-EPM) can be seen on CT
scan, but magnetic resonance imaging (MRI) is the imag-
ing technique of choice, having a greater sensitivity for
CPM than CT scan, and superior capacity for the demon-
stration of the lesions of EPM. Hyperintense lesions can be
seen on T2, FLAIR, as well as hypointense lesions on T1
weighted images. The lesions are non-contrast enhancing.
Diffusion weighted imaging (DWI), performed in early
phases, may have the capability of detecting unidentified
lesions on T2 and FLAIR. A finding of irreversible vaso-
genic edema in the DWI sequences is a signal alteration at
b-1,000 DWI without restriction in ADC. The timing of the
appearance of lesions on the MRI may be significantly
delayed: a repeated MRI after 10–14 days may reveal
lesions that weren’t visible on earlier scans (Fig. 1). The
lesions are always symmetrical and localized in the cere-
bellum, lateral geniculate body and less frequently in the
claustrum, midbrain, internal medullary lamella, mammil-
lary body, and medulla oblongata.
In our case the MRI, on the second day, showed in
FLAIR, T2 and DWI b-1,000 sequences a symmetrical
lesion in midbrain at the level of the inferior colliculus,
without contrast enhancement in post-Gadolinium IV
administration [2, 3].
General information on lithium use and side effects
Prof Gonnelli and Dr Bocchi: Lithium salts were
introduced in 1949 for the treatment of mania, but the
Table 1 Clinical data
1st day 2nd day 3rd day 4th day 5th day
GCS 15/15 11/15 4/15 3/15 3/15
PA (mmHg) 110/70 100/60 80/40 70/30 68/35
FC (bpm) 66 sr 70 sr 98 sr 137 a 132 a
sr sinus rhythm, a arrhythmic
Table 2 Laboratory tests
1st day 2nd day 3rd day 4th day 5th day
I pH 7.26 7.42 7.4 7.43 7.41
HCO3
- (mmol/l) 16,1 22,9 21,1 21,3 21,2
AG 15,6 11,3 10,1 11 11,7
Osm (mmol/kg) 317 320 318 310 303
Creat. (mg/dl) 1,71 1,93 2,34 3,3 –
BUN (mg/dl) 66 – – 80 –
Sodium (mEq/l) 152 154 150 146 –
Lithium (mmol/l) 2,36 – – 1,28 –
Hb (g/dl) 10,6 – – 10,1 –
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exact pharmacodynamics mechanism of Li? as a mood
stabilizer remains unclear. Li? competes with similar
weight ions such as sodium, potassium, calcium and
magnesium in various intra and extracellular molecu-
lar reactions, and this explains the diversity of its
effects [4]. In cells Li? tends to accumulate in place
of potassium altering the normal potassium gradient,
and causing malfunction of the sodium–potassium
pump resulting in intracellular accumulation of
sodium. In the brain, lithium slows down calcium-
mediated norepinephrine and dopamine release, and
also modifies adenylate ciclase and phospholipase-C
mediated responses. Despite recent advances in phar-
maceutical treatment of psychiatric disorders, lithium
salts remain frequently used particularly for the
treatments of bipolar disorders and major depression.
Use of lithium is limited by its narrow therapeutic
index. The therapeutic concentration that is considered
safe ranges from 0.5 to 1.1 mEq/l; however, serum
lithium concentrations do not reflect tissue levels, and
the correlation between lithium levels and toxicity is
poor. Therefore, long-term use of lithium presents
several side effects, such as mild hypercalcemia,
thyroid disorders, hypotension and dysrhythmias.
Moreover, up to 20–30 % of long-term treated patients
may develop nephrogenic diabetes insipidus (NDI.)
Lithium is the most common cause of acquired NDI,
which is usually reversible after the withdrawal of the
drug. Literature suggests that lithium inhibits the
ADH induced expression of the aquaporins in the
renal collecting ducts, mainly aquaporin 2, by mech-
anisms still not fully understood. Sometiimes in lith-
ium treated patients, chronic renal failure is present,
and also, though rarely, acute renal failure may occur.
Lithium and myelinolysis: review of literature
Dr Borselli and Dr Sartini: Central pontine and extra-
pontine osmotic demyelinating syndromes (CPM, EPM)
are very uncommon disorders characterized by non-
inflammatory lesions involving the pons, and sometimes
spreading to other areas. In CPM, the lesions are confined
to the pons, while in EPM are located to the basal ganglia,
cerebrum and cerebellum. The pathogenesis of this disease
is complex, and involves the inability of brain cells to
respond to rapid changes in osmolality of the interstitial
(extracellular) compartment of the brain, leading to dehy-
dration of energy-depleted cells with subsequent axonal
damage that occurs in characteristic areas. Overly rapid
correction of hyponatremia has been considered as the
main cause of osmotic demyelination syndromes, particu-
larly in patients with conditions leading to nutritional or
electrolyte stress.
Khan et al. [5] made the first mention of the cor-
relation between lithium intoxication and central pon-
tine myelinolysis. Fabisiak et al. [6] report a case in
which a psychiatric patient in treatment with lithium,
manifested blindness due to overdose of the drug. In
this case, central pontine myelinolysis with involve-
ment of the lateral geniculate nucleus was demon-
strated to be the aetiology. In the same issue of the
journal, a contribution by Swartz et al. [7] is published,
which mentions the same case, and states that the
central pontine myelinolysis may be a rare but possible
complication of lithium intoxication. Bejot et al. [8]
report a case of a young pregnant woman who devel-
oped pontine and extrapontine myelinolysis due to
lithium intoxication. In this case, the pathogenic
mechanism reported is attributed to the rapid correction
Fig. 1 1.5 T MRI of the brain shows a symmetric subtle high-
intensity signal alteration on fluid attenuated inversion-recovery
images (a) and diffusion-weighted (b: 1,000 s/mm2) images (b) of the
mid-posterior portion of the midbrain (arrows), without restricted
diffusion at apparent diffusion coefficient maps (c). These findings are
consistent with vasogenic oedema, and thus with myelinolysis
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of hyponatremia in consequence of renal diabetes in-
sipidus induced by lithium.
Discussion
Prof. Pastorelli and Dr Frizzi: the final diagnosis of the
case here reported was extra-pontine myelinolysis in a
patient with lithium intoxication and NDI. In this case
report, the primum movens was likely an accidental over-
dose of lithium as a consequence of dehydration due to an
episode of severe diarrhea. As described in the literature,
lithium intoxication may cause NDI, and this may explain
the low urinary specific gravity, and the worsening renal
function [1].
This sequence of events may have caused rapid increase
of sodium levels and plasmatic osmolarity (probably fol-
lowing a pre-existing diarrhoea induced hyponatremia);
Moreover, because of the sodium–potassium pump alter-
ation caused by lithium overdose, the true value of intra-
cellular sodium concentration is greater than in plasma.
Neurological symptoms were likely caused by hyperos-
molar impairment of cortico-bulbar tracts, and subsequent
flaccid paresis due to impairment of cortico-spinal tracts [9,
10]. The extra-pontine myelinolysis could be an explana-
tion for the severe alteration of neurological status, which
progressed despite a progressive reduction of lithium,
sodium and osmolarity alteration. The fever pathogenesis
may have been from a central origin combined with the
urinary tract infection.
This clinical case should make us reflect on the potential
dangers of lithium, often too readily prescribed by non-
expert physicians to elderly, and often poorly compliant,
patients. There also needs to be very close monitoring of
plasma lithium levels, in addition to paying attention to
clinical signs, such as a persistent polyuria or hyperosmo-
larity, because these could be important early warning
signs. It is therefore useful to reiterate that, in case of
lithium intoxication with altered neurological status despite
improvement blood tests, it is necessary to consider pontine
or extra-pontine myelinolysis as a rare but possible
complication.
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